GOLGA2 and myopathy: Human genetic studies have identified pathogenic variants in critical proteins in the vesicular trafficking pathway, resulting in myopathies in affected patients such as GOLGA2, BIDC2 and BET1 (Oates et al., 2013; Kotecha et al., 2021; Shamseldin et al., 2016; Neveling et al., 2013; Unger et al., 2016; Shomron et al., 2021; Donkervoort et al., 2021).